Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Wagey, Ravenska T. E.
and
Krieger, Charles
1998.
Progress in Drug Research.
p.
133.
Weber, Markus
and
Eisen, Andrew
1999.
Assessment of upper and lower motor neurons in Kennedy's disease: Implications for corticomotoneuronal PSTH studies.
Muscle & Nerve,
Vol. 22,
Issue. 3,
p.
299.
Eisen, A.
1999.
How to improve the diagnostic process.
Journal of Neurology,
Vol. 246,
Issue. S3,
p.
III6.
Swash, Michael
2000.
Shortening the time to diagnosis in ALS: the role of electrodiagnostic studies.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders,
Vol. 1,
Issue. sup1,
p.
S67.
Hirota, Nobuyuki
Eisen, Andrew
and
Weber, Markus
2000.
Complex fasciculations and their origin in amyotrophic lateral sclerosis and Kennedy's disease.
Muscle & Nerve,
Vol. 23,
Issue. 12,
p.
1872.
Maasilta, P.
Jokelainen, M.
Löytönen, M.
Sabel, C. E.
and
Gatrell, A. C.
2001.
Mortality from amyotrophic lateral sclerosis in Finland, 1986-1995.
Acta Neurologica Scandinavica,
Vol. 104,
Issue. 4,
p.
232.
Eisen, Andrew
and
Weber, Markus
2001.
The motor cortex and amyotrophic lateral sclerosis.
Muscle & Nerve,
Vol. 24,
Issue. 4,
p.
564.
Hu, Jie Hong
and
Krieger, Charles
2002.
Progress in Drug Research.
p.
71.
Weber, Markus
2002.
Emergent Measure for Clinical Trials: TMS - con.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders,
Vol. 3,
Issue. sup1,
p.
S113.
Hu, Jie Hong
Chernoff, Ken
Pelech, Steven
and
Krieger, Charles
2003.
Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over‐expressing mice.
Journal of Neurochemistry,
Vol. 85,
Issue. 2,
p.
422.
Hu, J.‐H.
Zhang, H.
Wagey, R.
Krieger, C.
and
Pelech, S. L.
2003.
Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord.
Journal of Neurochemistry,
Vol. 85,
Issue. 2,
p.
432.
Krampfl, Klaus
Mohammadi, Bahram
Komissarow, Leonid
Dengler, Reinhard
and
Bufler, Johannes
2004.
Mirror movements and ipsilateral motor evoked potentials in ALS.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders,
Vol. 5,
Issue. 3,
p.
154.
Orrell, RW
Lane, RJM
Ross, M
and
Orrell, Richard
2005.
Cochrane Database of Systematic Reviews.
Stewart, H.G.
Mackenzie, I.R.
Eisen, A.
Brännström, T.
Marklund, S.L.
and
Andersen, P.M.
2006.
Clinicopathological phenotype of ALS with a novel G72C SOD1 gene mutation mimicking a myopathy.
Muscle & Nerve,
Vol. 33,
Issue. 5,
p.
701.
Petrik, M. S.
Wilson, J. M. B.
Grant, S. C.
Blackband, S. J.
Tabata, R. C.
Shan, X.
Krieger, C.
and
Shaw, C. A.
2007.
Magnetic Resonance Microscopy and Immunohistochemistry of the CNS of the Mutant SOD Murine Model of ALS Reveals Widespread Neural Deficits.
NeuroMolecular Medicine,
Vol. 9,
Issue. 3,
p.
216.
Mohammadi, Bahram
Krampfl, Klaus
Kollewe, Katja
Seyfadini, Amir
Bufler, Johannes
and
Dengler, Reinhard
2007.
Correlation between distal motor latency and compound muscle action potential in amyotrophic lateral sclerosis.
Neurological Research,
Vol. 29,
Issue. 5,
p.
425.
Orrell, Richard W
Lane, Russell JM
and
Ross, Mark
2007.
Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease.
Cochrane Database of Systematic Reviews,
Vol. 2011,
Issue. 6,
Orrell, Richard W.
Lane, Russell J. M.
and
Ross, Mark
2008.
A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease.
Amyotrophic Lateral Sclerosis,
Vol. 9,
Issue. 4,
p.
195.
Eisen, Andrew
2009.
Amyotrophic lateral sclerosis—Evolutionary and other perspectives.
Muscle & Nerve,
Vol. 40,
Issue. 2,
p.
297.
Pavey, Amanda
Allen-Collinson, Jacquelyn
and
Pavey, Toby
2013.
The Lived Experience of Diagnosis Delivery in Motor Neurone Disease: A Sociological-Phenomenological Study.
Sociological Research Online,
Vol. 18,
Issue. 2,
p.
36.